| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |